rAd-p53 Gene Therapy for Advanced Oral and Maxillofacial Malignant Tumors

NCT00902083 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Oral and Maxillofacial Malignant Tumors

Interventions

DRUG: p53 gene with surgery
PROCEDURE: surgery
DRUG: p53 with chemotherapy
DRUG: p53 gene therapy

Sponsor

Shenzhen SiBiono GeneTech Co.,Ltd